Bantari W K Wardhani (Bantari Wk Wardhani)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Signaling Pathway

Epithelial Mesenchymal Transition

Cell Proliferation

Top Venues

Breast cancer (Dove Medical Press)

Journal of experimental pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Bantari W K Wardhani, Melva Louisa, Yukihide Watanabe, Rianto Setiabudy, Mitsuyasu Kato
TGF-β-Induced TMEPAI Promotes Epithelial-Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration. Breast cancer (Dove Medical Press) 13 (2021)
Bantari W K Wardhani, Meidi Utami Puteri, Yukihide Watanabe, Melva Louisa, Rianto Setiabudy, Mitsuyasu Kato
TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel. Journal of experimental pharmacology 12 (2020)